Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Clopidogrel hydrogen sulfate

🥰Excellent
Catalog No. T0182LCas No. 120202-66-6
Alias SR-25990C, (S)-(+)-Clopidogrel hydrogen sulfate, (S)-(+)-Clopidogrel bisulfate

Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation.

Clopidogrel hydrogen sulfate

Clopidogrel hydrogen sulfate

🥰Excellent
Purity: 99.57%
Catalog No. T0182LAlias SR-25990C, (S)-(+)-Clopidogrel hydrogen sulfate, (S)-(+)-Clopidogrel bisulfateCas No. 120202-66-6
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation.
Pack SizePriceAvailabilityQuantity
25 mg$30In Stock
50 mg$40In Stock
100 mg$50In Stock
200 mg$58In Stock
500 mg$81In Stock
1 mL x 10 mM (in DMSO)$50In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Clopidogrel hydrogen sulfate"

Select Batch
Purity:99.57%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation.
Targets&IC50
CYP2C19:524 nM (IC50), CYP2B6:18.2 nM (IC50)
In vitro
In a rat model of ulcer margins, daily administration of Clopidogrel (2 mg and 10 mg/kg) significantly reduced the proliferation of gastric epithelial cells induced by ulcers, as well as the expression of the EGF receptor and phosphorylated extracellular signal-regulated kinase. In rats with congestive heart failure, Clopidogrel enhanced the phosphorylation of AKT and eNOS, thereby improving vascular endothelial function and the bioavailability of nitric oxide.
In vivo
In RGM-1 cells, Clopidogrel (1 μM) inhibits the epidermal growth factor-induced activation of epidermal growth factor receptor, PERK expression, and cellular proliferation.
AliasSR-25990C, (S)-(+)-Clopidogrel hydrogen sulfate, (S)-(+)-Clopidogrel bisulfate
Chemical Properties
Molecular Weight419.9
FormulaC16H16ClNO2S·H2SO4
Cas No.120202-66-6
SmilesOS(O)(=O)=O.COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (130.98 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3815 mL11.9076 mL23.8152 mL119.0760 mL
5 mM0.4763 mL2.3815 mL4.7630 mL23.8152 mL
10 mM0.2382 mL1.1908 mL2.3815 mL11.9076 mL
20 mM0.1191 mL0.5954 mL1.1908 mL5.9538 mL
50 mM0.0476 mL0.2382 mL0.4763 mL2.3815 mL
100 mM0.0238 mL0.1191 mL0.2382 mL1.1908 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Clopidogrel hydrogen sulfate | purchase Clopidogrel hydrogen sulfate | Clopidogrel hydrogen sulfate cost | order Clopidogrel hydrogen sulfate | Clopidogrel hydrogen sulfate chemical structure | Clopidogrel hydrogen sulfate in vivo | Clopidogrel hydrogen sulfate in vitro | Clopidogrel hydrogen sulfate formula | Clopidogrel hydrogen sulfate molecular weight